To demonstrate the feasibility of achieving good hemodynamic results with valve‐in‐valve transcatheter aortic valve replacement (ViV TAVR) for degenerated 19 mm surgical bioprosthetic valves. Click to show full abstract
To demonstrate the feasibility of achieving good hemodynamic results with valve‐in‐valve transcatheter aortic valve replacement (ViV TAVR) for degenerated 19 mm surgical bioprosthetic valves.
               
Click one of the above tabs to view related content.